Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$504M |
| 2 |
Cigna
CI
|
+$469M |
| 3 |
Intuitive Surgical
ISRG
|
+$392M |
| 4 |
Procter & Gamble
PG
|
+$387M |
| 5 |
Parker-Hannifin
PH
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$357M |
| 2 |
Adeia
ADEA
|
+$356M |
| 3 |
Target
TGT
|
+$346M |
| 4 |
Salesforce
CRM
|
+$344M |
| 5 |
Eli Lilly
LLY
|
+$331M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 12.51% |
| 3 | Financials | 11.68% |
| 4 | Industrials | 8.82% |
| 5 | Consumer Discretionary | 6.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Invesco DB Base Metals Fund
DBB
$312M
| $6.88M | ﹤0.01% |
353,453
+150,738
| +74% | +$2.89M |
|
2002
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $6.86M | ﹤0.01% |
44,532
+11,896
| +36% | +$1.76M |
|
2003
Vicor
VICR
$9.56B
| $6.86M | ﹤0.01% |
127,611
+21,145
| +20% | +$1.11M |
|
2004
Frontdoor
FTDR
$5.1B
| $6.85M | ﹤0.01% |
329,202
-106,426
| -24% | -$2.34M |
|
2005
Aspen Aerogels
ASPN
$384M
| $6.84M | ﹤0.01% |
580,518
+475
| +0.1% | +$5.43K |
|
2006
Core Laboratories
CLB
$488M
| $6.84M | ﹤0.01% |
337,281
+3,817
| +1% | +$74K |
|
2007
FlexShares Global Upstream Natural Resources Index Fund
GUNR
$7.2B
| $6.83M | ﹤0.01% |
156,962
+41,525
| +36% | +$1.76M |
|
2008
Copa Holdings
CPA
$5.76B
| $6.83M | ﹤0.01% |
82,064
-7,690
| -9% | -$605K |
|
2009
Acadia Realty Trust
AKR
$3.09B
| $6.82M | ﹤0.01% |
475,414
-252,051
| -35% | -$3.56M |
|
2010
Campbell Soup
CPB
$6.55B
| $6.82M | ﹤0.01% |
119,979
-15,547
| -11% | -$816K |
|
2011
Bank of Montreal
BMO
$126B
| $6.8M | ﹤0.01% |
70,613
+20,617
| +41% | +$1.91M |
|
2012
Evolent Health
EVH
$348M
| $6.79M | ﹤0.01% |
241,913
+23,148
| +11% | +$664K |
|
2013
Schwab US Broad Market ETF
SCHB
$43.2B
| $6.79M | ﹤0.01% |
419,769
-46,698
| -10% | -$702K |
|
|
VGR
2014
DELISTED
Vector Group Ltd.
VGR
| $6.76M | ﹤0.01% |
569,887
-7,842
| -1% | -$82.8K |
|
2015
iShares Broad USD High Yield Corporate Bond ETF
USHY
$29.3B
| $6.74M | ﹤0.01% |
194,562
-310,515
| -61% | -$10.7M |
|
2016
Franklin Resources
BEN
$17.6B
| $6.72M | ﹤0.01% |
254,714
-1,748
| -0.7% | -$43.4K |
|
2017
iShares US Industrials ETF
IYJ
$1.98B
| $6.72M | ﹤0.01% |
69,625
+2,147
| +3% | +$202K |
|
2018
Lumen
LUMN
$6.57B
| $6.71M | ﹤0.01% |
1,285,819
-152,182
| -11% | -$935K |
|
2019
Pediatrix Medical
MD
$2.18B
| $6.69M | ﹤0.01% |
450,537
-25,574
| -5% | -$417K |
|
2020
Agios Pharmaceuticals
AGIO
$1.79B
| $6.68M | ﹤0.01% |
238,009
+77,932
| +49% | +$2.2M |
|
2021
iShares US Basic Materials ETF
IYM
$1.12B
| $6.67M | ﹤0.01% |
53,079
-39,119
| -42% | -$4.81M |
|
2022
Eagle Bancorp
EGBN
$846M
| $6.63M | ﹤0.01% |
150,566
-6,785
| -4% | -$307K |
|
2023
Lyft
LYFT
$6.02B
| $6.62M | ﹤0.01% |
601,098
-421,647
| -41% | -$5.08M |
|
2024
Tennant Co
TNC
$1.43B
| $6.62M | ﹤0.01% |
107,461
+11,541
| +12% | +$705K |
|
2025
Ascendis Pharma A/S
ASND
$16B
| $6.61M | ﹤0.01% |
54,136
-331
| -0.6% | -$38.4K |
|
Similar funds
Ameriprise's Q4 2022 Portfolio in Review
As of Q4 2022, Ameriprise held 4,135 positions worth $292B, up 7.9% from $270B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Ameriprise's Q4 2022 filing shows 152 new, 1,522 increased, 2,111 reduced and 185 closed positions. Its largest new stake was Abcam PLC: 5,014,378 shares worth $78M. The largest sale was CVS Health, an estimated $357M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ameriprise's largest Q4 2022 buy was Abcam PLC: 5,014,378 shares worth $78M.
- Ameriprise added most to Prologis in Q4 2022, an estimated $504M increase.
- Ameriprise's biggest Q4 2022 reduction was CVS Health, cutting an estimated $357M.
- Ameriprise fully exited Duke Realty Corp. in Q4 2022, selling an estimated $166M.
- Ameriprise's ten largest holdings make up 13% of its $292B portfolio in Q4 2022.
- Ameriprise opened 152 new positions and closed 185 in Q4 2022.
- Ameriprise's portfolio value rose 7.9% quarter-over-quarter to $292B.
Based on Ameriprise's 13F filing for Q4 2022, filed 14 Feb 2023.